Search

Human mitochondria contain a circular genome that encodes 13 subunits of the oxidative phosphorylation system. In addition to their role as powerhouses of the cells, mitochondria are also involved in innate immunity as the mitochondrial genome generates long double-stranded RNAs (dsRNAs) that can activate the dsRNA-sensing pattern recognition receptors. Recent evidence shows that these mitochondrial dsRNAs (mt-dsRNAs) are closely associated with the pathogenesis of human diseases that accompany inflammation and aberrant immune activation, such as Huntington's disease, osteoarthritis, and autoimmune Sjögren's syndrome. Yet, small chemicals that can protect cells from a mt-dsRNA-mediated immune response remain largely unexplored. Here, we investigate the potential of resveratrol (RES), a plant-derived polyphenol with antioxidant properties, on suppressing mt-dsRNA-mediated immune activation. We show that RES can revert the downstream response to immunogenic stressors that elevate mitochondrial RNA expressions, such as stimulation by exogenous dsRNAs or inhibition of ATP synthase. Through high-throughput sequencing, we find that RES can regulate mt-dsRNA expression, interferon response, and other cellular responses induced by these stressors. Notably, RES treatment fails to counter the effect of an endoplasmic reticulum stressor that does not affect the expression of mitochondrial RNAs. Overall, our study demonstrates the potential usage of RES to alleviate the mt-dsRNA-mediated immunogenic stress response. [ABSTRACT FROM AUTHOR]

Inverted Alu repeats (IRAlus) are abundantly found in the transcriptome, especially in introns and 3′ untranslated regions (UTRs). Yet, the biological significance of IRAlus embedded in 3′ UTRs remains largely unknown. Here, we find that 3′ UTR IRAlus silences genes involved in essential signaling pathways. We utilize J2 antibody to directly capture and map the double-stranded RNA structure of 3′ UTR IRAlus in the transcriptome. Bioinformatic analysis reveals alternative polyadenylation as a major axis of IRAlus-mediated gene regulation. Notably, the expression of mouse double minute 2 (MDM2), an inhibitor of p53, is upregulated by the exclusion of IRAlus during UTR shortening, which is exploited to silence p53 during tumorigenesis. Moreover, the transcriptome-wide UTR lengthening in neural progenitor cells results in the global downregulation of genes associated with neurodegenerative diseases, including amyotrophic lateral sclerosis, via IRAlus inclusion. Our study establishes the functional landscape of 3′ UTR IRAlus and its role in human pathophysiology. [Display omitted] • Direct capture and map inverted Alu repeats in 3′ UTRs using J2 antibody • Global APA as a major regulatory axis for IRAlus-mediated gene silencing • UTR shortening during tumorigenesis suppresses p53 via IRAlus exclusion • Global UTR lengthening results in neuronal-cell-specific gene silencing Ku et al. capture and map the dsRNA structures in the transcriptome to study the pathophysiological role of gene silencing by 3′ UTR IRAlus. Specifically, tumors can suppress p53 via IRAlus exclusion through shortening of MDM2 3′ UTR, whereas global enhancement of IRAlus-mediated gene silencing is associated with neurodegenerative diseases. [ABSTRACT FROM AUTHOR]

Mitochondria are essential regulators of innate immunity. They generate long mitochondrial double-stranded RNAs (mt-dsRNAs) and release them into the cytosol to trigger an immune response under pathological stress conditions. Yet the regulation of these self-immunogenic RNAs remains largely unknown. Here, we employ CRISPR screening on mitochondrial RNA (mtRNA)-binding proteins and identify NOP2/Sun RNA methyltransferase 4 (NSUN4) as a key regulator of mt-dsRNA expression in human cells. We find that NSUN4 induces 5-methylcytosine (m5C) modification on mtRNAs, especially on the termini of light-strand long noncoding RNAs. These m5C-modified RNAs are recognized by complement C1q-binding protein (C1QBP), which recruits polyribonucleotide nucleotidyltransferase to facilitate RNA turnover. Suppression of NSUN4 or C1QBP results in increased mt-dsRNA expression, while C1QBP deficiency also leads to increased cytosolic mt-dsRNAs and subsequent immune activation. Collectively, our study unveils the mechanism underlying the selective degradation of light-strand mtRNAs and establishes a molecular mark for mtRNA decay and cytosolic release. [Display omitted] • CRISPR screening of mt-RBPs reveals key regulators of mt-dsRNA expression • NSUN4 installs m5C RNA modification on mitochondrial mRNAs and lncRNAs • C1QBP recognizes m5C-modified mitochondrial RNAs and recruits PNPT1 • m5C modification marks the mitochondrial RNAs for decay and cytosolic release Through CRISPR screening of 89 mitochondrial RBPs, Kim et al. find that NSUN4 downregulates mitochondrial dsRNA expression by installing 5-methylcytosine modification on light-strand RNAs. The modified RNAs are recognized by C1QBP, which recruits PNPT1 to facilitate RNA turnover, and are released to the cytosol, where they activate the immune response. [ABSTRACT FROM AUTHOR]